European Patent for Replacement Heart Valve System
Summary
The European Patent Office has published a patent application (EP2024191704A1) for a replacement heart valve system. The publication date is March 11, 2026, and the inventors have not yet been designated. This notice serves as an informational update regarding a new patent in the medical device sector.
What changed
The European Patent Office (EPO) has published patent application EP2024191704A1 concerning a replacement heart valve system. The publication date is March 11, 2026. Notably, the designation of the inventor has not yet been filed, and the patent is classified under IPC A61F 2/24. The patent is designated for a broad range of European states.
This publication is primarily an informational notice regarding a new patent filing. It does not impose any new compliance obligations or deadlines on regulated entities. Manufacturers and medical device makers involved in heart valve technology should be aware of this patent application as it may relate to their intellectual property landscape and product development.
Source document (simplified)
REPLACEMENT HEART VALVE SYSTEM
Publication EP2024191704A1 Kind: A1 Mar 11, 2026
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
A61F 2/24 20060101AFI20240920BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Prosthetics (A61F) publishes new changes.